Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,268 | -6,581 | -12,564 | -5,329 | -3,602 |
| Depreciation Amortization | 559 | 202 | 840 | 624 | 407 |
| Accounts receivable | -288 | -213 | -22 | 119 | 122 |
| Other Working Capital | -152 | -496 | 755 | 1,054 | 316 |
| Other Operating Activity | 4,613 | 5,510 | 2,469 | -1,996 | -1,776 |
| Operating Cash Flow | $-2,536 | $-1,578 | $-8,522 | $-5,528 | $-4,533 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,930 | -222 | -1,474 | -1,183 | -743 |
| Other Investing Activity | -225 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,155 | $-222 | $-1,474 | $-1,183 | $-743 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 13,517 | 6,418 | 5,140 |
| Common Stock Issued | 4,738 | 13 | 403 | 403 | 403 |
| Other Financing Activity | -248 | -129 | -364 | -274 | -179 |
| Financing Cash Flow | $4,490 | $-116 | $13,556 | $6,547 | $5,364 |
| Exchange Rate Effect | 14 | -3 | 59 | -13 | -12 |
| Beginning Cash Position | 5,355 | 5,355 | 1,736 | 1,736 | 1,736 |
| End Cash Position | 5,168 | 3,436 | 5,355 | 1,559 | 1,812 |
| Net Cash Flow | $-201 | $-1,919 | $3,619 | $-164 | $88 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,536 | -1,578 | -8,522 | -5,528 | -4,533 |
| Capital Expenditure | -1,930 | -222 | -1,474 | -1,183 | -743 |
| Free Cash Flow | -4,466 | -1,800 | -9,996 | -6,711 | -5,276 |